A new clinical decision support tool for improving the adequacy of anticoagulant therapy and reducing the incidence of stroke in nonvalvular atrial fibrillation: A randomized clinical trial in primary care

INTRODUCTION: Atrial fibrillation (AF) is the most common cardiac arrhythmia and increases the risk of ischemic stroke 4 to 5-fold. The first choice of anticoagulant therapy (AT) is the vitamin K antagonist (VKA). Contraindication to VKA or poor control of the International Normalized Ratio leads to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalmau Llorca, Maria Rosa, Gonçalves, Alessandra Queiroga, Forcadell Drago, Emma, Fernández-Sáez, José, Hernández Rojas, Zojaina, Pepió Vilaubí, Josep Maria, Rodríguez Cumplido, Dolores, Morral Parente, Rosa Maria, Aguilar Martín, Carina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
6400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779750/
https://www.ncbi.nlm.nih.gov/pubmed/29504981
http://dx.doi.org/10.1097/MD.0000000000009578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779750/
https://www.ncbi.nlm.nih.gov/pubmed/29504981
http://dx.doi.org/10.1097/MD.0000000000009578

Ejemplares similares